118 related articles for article (PubMed ID: 26307099)
1. A "universal" model of metastatic cancer, its parametric forms and their identification: what can be learned from site-specific volumes of metastases.
Hanin L; Seidel K; Stoevesandt D
J Math Biol; 2016 May; 72(6):1633-62. PubMed ID: 26307099
[TBL] [Abstract][Full Text] [Related]
2. The natural history of renal cell carcinoma with pulmonary metastases illuminated through mathematical modeling.
Hanin L; Jandrig B; Pavlova L; Seidel K
Math Biosci; 2019 Mar; 309():118-130. PubMed ID: 30703380
[TBL] [Abstract][Full Text] [Related]
3. Uncovering the natural history of cancer from post-mortem cross-sectional diameters of hepatic metastases.
Hanin L; Rose J
Math Med Biol; 2016 Dec; 33(4):397-416. PubMed ID: 26239139
[TBL] [Abstract][Full Text] [Related]
4. Reconstruction of the natural history of metastatic cancer and assessment of the effects of surgery: Gompertzian growth of the primary tumor.
Hanin L; Bunimovich-Mendrazitsky S
Math Biosci; 2014 Jan; 247():47-58. PubMed ID: 24211826
[TBL] [Abstract][Full Text] [Related]
5. Suppression of Metastasis by Primary Tumor and Acceleration of Metastasis Following Primary Tumor Resection: A Natural Law?
Hanin L; Rose J
Bull Math Biol; 2018 Mar; 80(3):519-539. PubMed ID: 29302774
[TBL] [Abstract][Full Text] [Related]
6. Modeling growth kinetics and statistical distribution of oligometastases.
Withers HR; Lee SP
Semin Radiat Oncol; 2006 Apr; 16(2):111-9. PubMed ID: 16564446
[TBL] [Abstract][Full Text] [Related]
7. Seeing the invisible: how mathematical models uncover tumor dormancy, reconstruct the natural history of cancer, and assess the effects of treatment.
Hanin L
Adv Exp Med Biol; 2013; 734():261-82. PubMed ID: 23143983
[TBL] [Abstract][Full Text] [Related]
8. A quantitative insight into metastatic relapse of breast cancer.
Hanin L; Pavlova L
J Theor Biol; 2016 Apr; 394():172-181. PubMed ID: 26801873
[TBL] [Abstract][Full Text] [Related]
9. Does extirpation of the primary breast tumor give boost to growth of metastases? Evidence revealed by mathematical modeling.
Hanin L; Korosteleva O
Math Biosci; 2010 Feb; 223(2):133-41. PubMed ID: 19932124
[TBL] [Abstract][Full Text] [Related]
10. Mathematical modeling of tumor growth and metastatic spreading: validation in tumor-bearing mice.
Hartung N; Mollard S; Barbolosi D; Benabdallah A; Chapuisat G; Henry G; Giacometti S; Iliadis A; Ciccolini J; Faivre C; Hubert F
Cancer Res; 2014 Nov; 74(22):6397-407. PubMed ID: 25217520
[TBL] [Abstract][Full Text] [Related]
11. Nonparametric estimation of solid cancer size at metastasis and probability of presenting with metastasis at detection.
Xu JL; Prorok PC
Biometrics; 1997 Jun; 53(2):579-91. PubMed ID: 9192453
[TBL] [Abstract][Full Text] [Related]
12. Effects of Surgery and Chemotherapy on Metastatic Progression of Prostate Cancer: Evidence from the Natural History of the Disease Reconstructed through Mathematical Modeling.
Hanin L; Zaider M
Cancers (Basel); 2011 Sep; 3(3):3632-60. PubMed ID: 24212971
[TBL] [Abstract][Full Text] [Related]
13. [On the growth characteristics of human osseous sarcoma metastases: mathematical calculations and clinical consequences (author's transl)].
Schramm W; Thieler P; Münzenberg KJ
Z Orthop Ihre Grenzgeb; 1977 Dec; 115(6):859-65. PubMed ID: 272086
[TBL] [Abstract][Full Text] [Related]
14. Histological progression of small intrapulmonary metastatic tumor from primary lung adenocarcinoma.
Aokage K; Ishii G; Yoshida J; Hishida T; Nishimura M; Nagai K; Ochiai A
Pathol Int; 2010 Dec; 60(12):765-73. PubMed ID: 21091834
[TBL] [Abstract][Full Text] [Related]
15. A stochastic model for the sizes of detectable metastases.
Hanin L; Rose J; Zaider M
J Theor Biol; 2006 Dec; 243(3):407-17. PubMed ID: 16930629
[TBL] [Abstract][Full Text] [Related]
16. A simulation model of the natural history of human breast cancer.
Koscielny S; Tubiana M; Valleron AJ
Br J Cancer; 1985 Oct; 52(4):515-24. PubMed ID: 4063132
[TBL] [Abstract][Full Text] [Related]
17. [Frequency and distribution pattern of distant metastases in patients with ENT tumors and their consequences for pretherapeutic staging].
Dietl B; Marienhagen J; Schaefer C; Pohl F; Kölbl O
Strahlenther Onkol; 2007 Mar; 183(3):138-43. PubMed ID: 17340072
[TBL] [Abstract][Full Text] [Related]
18. PET/CT: will it change the way that we use CT in cancer imaging?
Hicks RJ; Ware RE; Lau EW
Cancer Imaging; 2006 Oct; 6(Spec No A):S52-62. PubMed ID: 17114079
[TBL] [Abstract][Full Text] [Related]
19. Consolidated mathematical growth model of the primary tumor and secondary distant metastases of breast cancer (CoMPaS).
Tyuryumina EY; Neznanov AA
PLoS One; 2018; 13(7):e0200148. PubMed ID: 29979733
[TBL] [Abstract][Full Text] [Related]
20. Does whole-body 2-[18F]-fluoro-2-deoxy-D-glucose positron emission tomography have an advantage over thoracic positron emission tomography for staging patients with lung cancer?
Aquino SL; Fischman AJ
Chest; 2004 Sep; 126(3):755-60. PubMed ID: 15364753
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
